By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Advion BioSciences today announced that it has signed a definitive agreement to sell its BioServices division to Quintiles Transnational for an undisclosed amount of cash.

Advion BioServices is a bioanalytical lab offering pharmacokinetic/pharmacodynamics testing and other services. The sale will allow Advion to focus on its core systems and consumables business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.